Healthcare
Live Price
Offline$3.13
+0.00% today
1Y Change
-23.66%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 253 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Swedencare AB (publ) (SWDCF) is a Healthcare stock with a market cap of $4.30B and listed on OTC. The stock last traded around $3.13 and down 23.7% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of +6.1%, EPS growth of -43.5%, a dividend yield of 1.0%. What stands out right now is revenue +6.1%, EPS -43.5%, free cash flow -4.2% with operating margin 5.4% and ROIC 1.0%. The dividend is present but secondary, with a yield around 1.0%. Valuation already assumes a fairly strong business story at P/E 87.0 and price/sales 1.6. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SWDCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SWDCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SWDCF Max Drawdown
-48.35%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SWDCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$770.4M
-57.9% YoY
FY Net Income
$54.6M
-42.2% YoY
Free Cash Flow
$98.1M
-47.1% YoY
Revenue Growth
+6.1%
EPS Growth
-43.5%
Gross Margin
44.0%
Net Margin
1.8%
Income statement
SEK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.7B | 2.5B | 2.3B | 1.8B | 770M |
| Gross Profit | 1.5B | 1.5B | 1.3B | 1.0B | 386M |
| Operating Income | 141M | 225M | 173M | 120M | 65M |
| EBITDA | 468M | 549M | 484M | 390M | 139M |
| Net Income | 56M | 99M | 59M | 95M | 55M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
SEK
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 103M | 187M | 237M | 245M | 136M |
| Total Assets | 9.5B | 10.3B | 9.5B | 10.0B | 3.5B |
| Total Liabilities | 2.8B | 2.3B | 2.3B | 2.5B | 1.1B |
| Shareholder Equity | 6.7B | 8.0B | 7.2B | 7.5B | 2.4B |
| Total Debt | 2.1B | 1.5B | 1.7B | 1.9B | 722M |
| Net Debt | 2.0B | 1.3B | 1.4B | 1.7B | 585M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
126M
-51.6% YoY
Capital Expenditures
28M
+62.8% YoY
Free Cash Flow
98M
-47.1% YoY
Key ratios
Gross Margin
44.0%
Operating Margin
5.4%
Net Margin
1.8%
ROE
0.7%
Debt / Equity
0.25x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.